Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors

Abstract : An efficient synthetic strategy able to modulate the structure of the tetrahydropyridine isoindolone (Valmerin) skeleton was developed. A library of more than 30 novel final structures was generated. Biological activities on CDK5 and GSK3 as well as cellular effects on cancer cell lines were measured for each novel compound. Additionally to support the SAR, a docking study was performed. A potent GSK3/CDK5 dual inhibitor (37, IC50 CDK5/GSK3 35/7 nM) was obtained. Best antiproliferative effects were obtained on lung and prostate cell lines with IC50 = 20 nM
Type de document :
Article dans une revue
European Journal of Medicinal Chemistry, Elsevier, 2016, 115, pp.311--325. 〈10.1016/j.ejmech.2016.02.072〉
Liste complète des métadonnées

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01295635
Contributeur : Laurent Jonchère <>
Soumis le : jeudi 31 mars 2016 - 14:16:11
Dernière modification le : vendredi 16 novembre 2018 - 01:41:52

Identifiants

Citation

Aziz Ouach, Rajâa Boulahjar, Christine Vala, Stéphane Bourg, Pascal Bonnet, et al.. Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors. European Journal of Medicinal Chemistry, Elsevier, 2016, 115, pp.311--325. 〈10.1016/j.ejmech.2016.02.072〉. 〈hal-01295635〉

Partager

Métriques

Consultations de la notice

241